Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Clinical Decision Services In Europe
9 services found
Manufactured by:Medexter Healthcare based inVienna, AUSTRIA
Please contact us, if you are interested in a workshop or training. Our last workshop was: “Introduction into Clinical Decision Support & Arden Syntax” Date: May 27, 2019 (one day prior to dHealth 2019 conference, also in Vienna, Austria). Location: FH Technikum Wien, HS A3.14, Höchstädtplatz 5 (access via Höchstädtplatz 6), ...
Manufactured by:Senzime AB Uppsala based inUppsala, SWEDEN
The result is therefore subjective and unreliable, regardless of the clinician’s level of experience or training. Low, but still clinically meaningful degrees of neuromuscular blockade can only be measured using a quantitative, objective, monitoring device. A residual neuromuscular block of TOFR > 0.4 cannot be reliably detected by tactile or visual means even by an ...
by:Genmab A/S based inCopenhagen V, DENMARK
We aim to invent, develop and commercialize differentiated antibody-based products, which can be utilized in a modular fashion to create unique and tailored therapeutics to transform cancer ...
Manufactured by:S3 Connected Health based inDublin, IRELAND
S3 Connected Health are a leading partner for pharma-sponsored digital health solutions that support patients and clinicians in the management of chronic diseases. These solutions allow pharma to holistically tackle disease categories and improve healthcare outcomes. We take our clients from concept, through creation, development of software as a medical device (SaMD) for regulated solutions, and ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Immunogram, Veracyte’s advanced analytics platform, integrates multi-omic data sets and analyzes them into a single per patient view of key biomarker signatures, specific to their own Tumor Microenvironment. This analytics platform delivers valuable insights to improve patient care and help clinical researchers make informed decisions to advance ...
Manufactured by:Medexter Healthcare based inVienna, AUSTRIA
Arden Syntax is a language for the representation and processing of clinical knowledge in a standardized way. Our ArdenSuite is based on this syntax. The software suite is a powerful tool that will help shape the future of healthcare information technology. As it is extremely versatile and flexible, it can be applied to a grand variety of clinical tasks and has proven an effective way to ...
by:PharmaLex GMBH based inFriedrichsdorf, GERMANY
The Global Statistics and Data Science (GSDS) team at PharmaLex delivers analytical support for the development of medical products–from early research through pre-clinical to late phase studies, plus manufacturing and health economics. We support our clients every step of the way–from discovery and non-clinical requirements to early strategic ...
by:Almac Group based inCraigavon, UNITED KINGDOM
Almac Diagnostic Services can also help Biopharma clients validate reliable Pharmacodynamic (PD) Biomarker assays that can help provide invaluable guidance within their drug development programmes. Almac also has extensive experience in the discovery of clinically applicable biomarkers, through our own range of Almac proprietary assays (DDIR, Prostate Dx, ColDx, Angio, and EMT) and through ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Unlocking the potential of precision medicine with Artificial Intelligence – enabled data-driven insights. Advance targeted therapy development by harnessing the power of data and multimodal analytics. Advances in molecular and imaging techniques have resulted in an explosion of data, providing an unprecedented opportunity to identify clinically relevant drug targets. Yet, deciphering and ...